简介：
Overview
This article describes a method for measuring the activation of Fc-mediated effector functions by antibodies targeting the influenza virus hemagglutinin. The assay can be adapted for monoclonal antibodies or polyclonal sera against other viral glycoproteins.
Key Study Components
Area of Science
Background
- Fc-mediated immunity plays a crucial role in the immune response.
- Understanding antibody interactions with viral proteins is essential for vaccine development.
- This method allows for rapid assessment of antibody efficacy.
Purpose of Study
- To evaluate the ability of antibodies to activate Fc-mediated effector functions.
- To provide a protocol that can be completed within 24 hours.
- To facilitate research in immunology and vaccine efficacy.
Methods Used
- Transfection of human embryonic kidney 293 cells with DNA coding for viral hemagglutinin.
- Measurement of antibody-dependent cellular cytotoxicity.
- Use of a 96-well plate format for high-throughput analysis.
- Data analysis conducted within 24 hours post-experiment.
Main Results
- The method successfully measures Fc-mediated effector functions.
- Results can be obtained quickly, enhancing research efficiency.
- Adaptable for various antibodies targeting different viral glycoproteins.
Conclusions
- This assay provides a valuable tool for assessing antibody efficacy.
- It contributes to the understanding of Fc-mediated immunity.
- The rapid turnaround time supports timely research advancements.
What is Fc-mediated immunity?
Fc-mediated immunity refers to the immune responses triggered by the Fc region of antibodies, which can activate various effector functions.
How long does the assay take?
The entire assay can be completed within 24 hours, from material preparation to data analysis.
Can this method be used for other viruses?
Yes, the assay can be adapted to assess antibodies targeting other viral surface glycoproteins.
What type of cells are used in this protocol?
Human embryonic kidney 293 cells are used for transfection in this protocol.
Who demonstrated this procedure?
Mark Bailey, a graduate student from Peter Palese's laboratory, demonstrated this procedure.
What is the main advantage of this technique?
The main advantage is the rapid assessment of antibody efficacy, allowing for timely research outcomes.
繁體中文
